1. The remuneration for the intra-Community acquisition of pharmaceuticals by a statutory health insurance company is based on the – discounted – amount paid by the latter to the respective mail-order pharmacy plus the manufacturer discount paid by the pharmaceutical company to the pharmacy.
2. Taking into account the manufacturer discount as part of the remuneration does not violate the principle of VAT neutrality in the case of deliveries of pharmaceuticals in a domestic supply chain – with the exception of mail order pharmacies – from a pharmaceutical company to a wholesaler and a mail order pharmacy to a statutory health insurance company.
Source: BFH, ruling v. December 10th, 2020, VR 34/18
Latest Posts in "Germany"
- German E-Commerce Group Achieves Multi-Country VAT Compliance Post-OSS Suspension with hellotax Support
- VAT Deduction for In-Kind Formation of a GmbH with Car Contribution
- Briefing document & Podcast: Germany E-Invoicing B2B Mandate, Timeline and Compliance
- General Court VAT case – T-569/25 (X-GmbH) – Questions – Can good faith be excluded from VAT assessment procedure?
- Emergency Service Provision Exempt from VAT Under § 4 Nr. 14 UStG by StB Michael Seifert